Identification of a Small Molecule As Inducer of Ferroptosis and Apoptosis Through Ubiquitination of GPX4 in Triple negative breast cancer Cells

Overview

Journal J Hematol Oncol

Publisher Biomed Central

Specialties Hematology
Oncology

Date 2021 Jan 21

PMID 33472669

Citations 171

Authors

Yahui Ding

Xiaoping Chen

Can Liu

Weizhi Ge

Qin Wang

Xin Hao

Mengmeng Wang

Yue Chen

Quan Zhang

Affiliations

Soon will be listed here.

Abstract

Background: TNBC is the most aggressive breast cancer with higher recurrence and mortality rate than other types of breast cancer. There is an urgent need for identification of therapeutic agents with unique mode of action for overcoming current challenges in TNBC treatment.

Methods: Different inhibitors were used to study the cell death manner of DMOCPTL. RNA silencing was used to evaluate the functions of GPX4 in ferroptosis and apoptosis of TNBC cells and functions of EGR1 in apoptosis. Immunohistochemical assay of tissue microarray were used for investigating correlation of GPX4 and EGR1 with TNBC. Computer-aided docking and small molecule probe were used for study the binding of DMOCPTL with GPX4.

Results: DMOCPTL, a derivative of natural product parthenolide, exhibited about 15-fold improvement comparing to that of the parent compound PTL for TNBC cells. The cell death manner assay showed that the anti-TNBC effect of DMOCPTL mainly by inducing ferroptosis and apoptosis through ubiquitination of GPX4. The probe of DMOCPTL assay indicated that DMOCPTL induced GPX4 ubiquitination by directly binding to GPX4 protein. To the best of our knowledge, this is the first report of inducing ferroptosis through ubiquitination of GPX4. Moreover, the mechanism of GPX4 regulation of apoptosis is still obscure. Here, we firstly reveal that GPX4 regulated mitochondria-mediated apoptosis through regulation of EGR1 in TNBC cells. Compound 13, the prodrug of DMOCPTL, effectively inhibited the growth of breast tumor and prolonged the lifespan of mice in vivo, and no obvious toxicity was observed.

Conclusions: These findings firstly revealed novel manner to induce ferroptosis through ubiquitination of GPX4 and provided mechanism for GPX4 inducing mitochondria-mediated apoptosis through up-regulation of EGR1 in TNBC cells. Moreover, compound 13 deserves further studies as a lead compound with novel mode of action for ultimate discovery of effective anti-TNBC drug.

Citing Articles

Curcumol promotes ferroptosis of colon cancer by targeting the ubiquitination and degradation of GPX4.

Zhao W, Yan Q, Liu L, Hou D, Xiang D, Tang D J Tradit Complement Med. 2025; 15(2):170-181.

PMID: 40060150 PMC: 11883637. DOI: 10.1016/j.jtcme.2024.08.006.

The marine xanthophyll diatoxanthin as ferroptosis inducer in MDAMB231 breast cancer cells.

Sansone C, Pistelli L, Brunet C Sci Rep. 2025; 15(1):8146.

PMID: 40059233 PMC: 11891320. DOI: 10.1038/s41598-025-91519-6.

Current Status and Future Directions of Ferroptosis Research in Breast Cancer: Bibliometric Analysis.

Luo J, Deng Y, Lu S, Chen S, He R, Qin D Interact J Med Res. 2025; 14:e66286.

PMID: 40009842 PMC: 11904379. DOI: 10.2196/66286.

Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells.

Xie C, Chan L, Pang Y, Shang Y, Wang W, Zhao L Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39998626 DOI: 10.1007/s00210-025-03927-0.

THBS1 in macrophage-derived exosomes exacerbates cerebral ischemia-reperfusion injury by inducing ferroptosis in endothelial cells.

Liu C, Sui H, Li Z, Sun Z, Li C, Chen G J Neuroinflammation. 2025; 22(1):48.

PMID: 39994679 PMC: 11854006. DOI: 10.1186/s12974-025-03382-x.

References

Liang C, Zhang X, Yang M, Dong X . Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019; 31(51):e1904197. DOI: 10.1002/adma.201904197. View

Denkert C, Liedtke C, Tutt A, von Minckwitz G . Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. Lancet. 2016; 389(10087):2430-2442. DOI: 10.1016/S0140-6736(16)32454-0. View

Guzman M, Rossi R, Neelakantan S, Li X, Corbett C, Hassane D . An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood. 2007; 110(13):4427-35. PMC: 2234793. DOI: 10.1182/blood-2007-05-090621. View

Sakamoto K, Sogabe S, Kamada Y, Matsumoto S, Kadotani A, Sakamoto J . Discovery of GPX4 inhibitory peptides from random peptide T7 phage display and subsequent structural analysis. Biochem Biophys Res Commun. 2016; 482(2):195-201. DOI: 10.1016/j.bbrc.2016.11.035. View

Yu H, Yang C, Jian L, Guo S, Chen R, Li K . Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor. Oncol Rep. 2019; 42(2):826-838. DOI: 10.3892/or.2019.7189. View

Mou Y, Wang J, Wu J, He D, Zhang C, Duan C . Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019; 12(1):34. PMC: 6441206. DOI: 10.1186/s13045-019-0720-y. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

Ghantous A, Sinjab A, Herceg Z, Darwiche N . Parthenolide: from plant shoots to cancer roots. Drug Discov Today. 2013; 18(17-18):894-905. DOI: 10.1016/j.drudis.2013.05.005. View

Zhang Q, Lu Y, Ding Y, Zhai J, Ji Q, Ma W . Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. J Med Chem. 2012; 55(20):8757-69. DOI: 10.1021/jm301064b. View

10.

Chen M, Wang S, Hsu C, Yin P, Yeh T, Lee H . CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2α-ATF4 pathway. Oncotarget. 2018; 8(70):114588-114602. PMC: 5777716. DOI: 10.18632/oncotarget.23055. View

11.

Yu H, Guo P, Xie X, Wang Y, Chen G . Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J Cell Mol Med. 2016; 21(4):648-657. PMC: 5345622. DOI: 10.1111/jcmm.13008. View

12.

Gluz O, Liedtke C, Gottschalk N, Pusztai L, Nitz U, Harbeck N . Triple-negative breast cancer--current status and future directions. Ann Oncol. 2009; 20(12):1913-27. DOI: 10.1093/annonc/mdp492. View

13.

Gaschler M, Andia A, Liu H, Csuka J, Hurlocker B, Vaiana C . FINO initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol. 2018; 14(5):507-515. PMC: 5899674. DOI: 10.1038/s41589-018-0031-6. View

14.

Hassannia B, Vandenabeele P, Vanden Berghe T . Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 2019; 35(6):830-849. DOI: 10.1016/j.ccell.2019.04.002. View

15.

Yu M, Gai C, Li Z, Ding D, Zheng J, Zhang W . Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells. Cancer Sci. 2019; 110(10):3173-3182. PMC: 6778638. DOI: 10.1111/cas.14181. View

16.

Vagia E, Mahalingam D, Cristofanilli M . The Landscape of Targeted Therapies in TNBC. Cancers (Basel). 2020; 12(4). PMC: 7226210. DOI: 10.3390/cancers12040916. View

17.

Zhao H, Ji B, Chen J, Huang Q, Lu X . Gpx 4 is involved in the proliferation, migration and apoptosis of glioma cells. Pathol Res Pract. 2017; 213(6):626-633. DOI: 10.1016/j.prp.2017.04.025. View

18.

Ma S, Henson E, Chen Y, Gibson S . Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis. 2016; 7:e2307. PMC: 4973350. DOI: 10.1038/cddis.2016.208. View

19.

Yang W, Sriramaratnam R, Welsch M, Shimada K, Skouta R, Viswanathan V . Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014; 156(1-2):317-331. PMC: 4076414. DOI: 10.1016/j.cell.2013.12.010. View

20.

Lesiak K, Koprowska K, Zalesna I, Nejc D, Duchler M, Czyz M . Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro. Melanoma Res. 2009; 20(1):21-34. DOI: 10.1097/CMR.0b013e328333bbe4. View